CiBOR develops advanced composite materials for bioscience and medical applications, including orthopedic implants. Mr. Sullivan earned his degree in economics from Benedictine College in Atchinson and has led four start-ups in life sciences during his career. Most recently, Mr. Sullivan served as CEO of Interface Biologics in Toronto, Ontario.
Read the Wichita Examiner report on Richard Sullivan.
Read more about biomaterials companies:
– Akron Biomaterials Commercialization Hub Receives $250,000 Grant for New Technology Development
– B1 Medical, Invibio Create Development Partnership for New PEEK-OPTIMA System
– Wound Management Technologies Acquires Resorbable Orthopedics
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
